protocolSection identificationModule nctId: NCT06262789, orgStudyIdInfo id: 49RC23_0011, briefTitle: RAT-HEMATO : Return to Work After Malignant Hemopathy, acronym: RAT-HEMATO, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-15, primaryCompletionDateStruct date: 2027-04-01, completionDateStruct date: 2027-04-01, studyFirstPostDateStruct date: 2024-02-16, lastUpdatePostDateStruct date: 2024-02-16, sponsorCollaboratorsModule leadSponsor name: University Hospital, Angers, class: OTHER_GOV, descriptionModule briefSummary: Return to work (RTW) of patients after cancer treatment has been a topic of growing interest for the past two decades. Advances in cancer care have led to better patient survival, with some cancers considered as chronic or even cured diseases. The return of patients to their "pre-cancer life" can thus become an objective. Indeed, RTW after cancer is associated with improved quality of life for patients in several studies (improved financial status, improved social contacts, return of functional abilities and improved self-esteem). However, many difficulties can interfere with RTW. Many factors have been identified: disease, treatment, patient and occupational factors. The feeling of "return-to-work self-efficacy" is one of the main psychological determinants and its interest has been recently demonstrated in oncology. It corresponds to a cognitive mechanism based on expectations and/or beliefs of an individual about being able to carry out the actions required to achieve a goal, in this case RTW. The majority of studies on RTW concerns solid cancer and are retrospective. Very few studies have focused on hematological malignancies, whose prognosis was, until recently, worse. Moreover, very few interventional studies exist. There is therefore a significant need for prospective studies with appropriate methodological tools to reliably assess the benefit of interventional measures on RTW. The investigators propose to conduct a prospective, comparative, randomized, multicenter study evaluating the impact of an early RTW-consultation in patients who have been treated for a hematological malignancy. The investigators hypothesize that this consultation will improve patients' RTW rates and RTW quality., conditionsModule conditions: Leukemia, conditions: Lymphoma, conditions: Multiple Myeloma, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: NONE, enrollmentInfo count: 264, type: ESTIMATED, armsInterventionsModule interventions name: "Return-to-work after cancer" consultation, outcomesModule primaryOutcomes measure: Return-to-work rate at 1 year (percentage), secondaryOutcomes measure: Cumulative incidence of return-to-work at 1 year, secondaryOutcomes measure: Change or not of the professional situation in the 2 arms, secondaryOutcomes measure: Factors influencing return to work, secondaryOutcomes measure: Quality of life (SF-12 score) evolution, secondaryOutcomes measure: Anxiety and depression (HAD scale) evolution, secondaryOutcomes measure: Return-to-work self-efficacy (RTW-SE-11 scale) evolution, secondaryOutcomes measure: Self-assessment of the benefit of the "return-to-work after cancer" consultation, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 55 Years, stdAges: ADULT, contactsLocationsModule locations facility: Angers University hospital, city: Angers, country: France, contacts name: PAILLASSA Jérome, MD, role: CONTACT, phone: 02.41.35.45.24, phoneExt: +33, email: jerome.paillassa@chu-angers.fr, geoPoint lat: 47.46667, lon: -0.55, locations facility: Brest University Hospital, Morvan Site, city: Brest, country: France, contacts name: Marie-Anne Couturier, MD, role: CONTACT, phone: 02.98.22.30.37, email: marie-anne.couturier@chu-brest.fr, geoPoint lat: 48.3903, lon: -4.48628, locations facility: Caen University hospital, city: Caen, country: France, contacts name: Ghandi Laurent DAMAJ, MD, role: CONTACT, phone: 02.31.27.21.40, phoneExt: +33, email: damaj-gl@chu-caen.fr, geoPoint lat: 49.18585, lon: -0.35912, locations facility: Rennes University Hospital, Pontchaillou site, city: Rennes, country: France, contacts name: Roch HOUOT, MD, role: CONTACT, phone: 02.99.28.42.91, phoneExt: +33, email: roch.houot@chu-rennes.fr, geoPoint lat: 48.11198, lon: -1.67429, locations facility: Centre Henri Becquerel, city: Rouen, country: France, contacts name: Stéphane LEPRETRE, MD, role: CONTACT, phone: 02.32.08.22.23, phoneExt: +33, email: stephane.lepretre@chb.unicancer.fr, geoPoint lat: 49.44313, lon: 1.09932, locations facility: Rouen University Hospital, city: Rouen, country: France, contacts name: Laetitia ROLLIN, MD, role: CONTACT, phone: 02.32.88.82.69, email: laetitia.rollin@chu-rouen.fr, geoPoint lat: 49.44313, lon: 1.09932, locations facility: Tours University Hospital, Bretonneau Site, city: Tours, country: France, contacts name: Emmanuel GYAN, role: CONTACT, phone: 02.47.47.38.11, email: e.gyan@chu-tours.fr, geoPoint lat: 47.38333, lon: 0.68333, hasResults: False